Crossmark

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice

Crossref DOI link: https://doi.org/10.1038/s41598-018-22116-z

Published Online: 2018-03-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Manvich, Daniel F.

Webster, Kevin A.

Foster, Stephanie L.

Farrell, Martilias S. http://orcid.org/0000-0002-9520-6209
Ritchie, James C.

Porter, Joseph H.

Weinshenker, David
License Information

Text and Data Mining valid from 2018-03-01

Version of Record valid from 2018-03-01
More Information

Article History

Received: 4 January 2018

Accepted: 15 February 2018

First Online: 1 March 2018

Competing Interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below